Announce Date | 01/29/2025 |
EPS Normalized Actual | $0.73 (Miss by $-0.044) |
EPS GAAP Actual | $0.73 (Miss by $-0.044) |
Revenue Actual | $25.707B |
Revenue Surprise | Beat by $25707M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 7.9275 | 33.72 | 6.27769 | 9.58536 | 1 |
Dec 2028 | 6.9525 | 38.44 | 5.55474 | 8.23426 | 9 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.72 | 0.72 | 25.707B | 2.1% | 25707M |
FQ3 2024 (Sep 2024) | 1 | 1 | 20.016B | -16.66% | 20016M |
FQ2 2024 (Jun 2024) | 0.46 | 0.46 | 25.5B | 2.25% | 25500M |
FQ1 2024 (Mar 2024) | 0.35 | 0.35 | 21.301B | -9.52% | 21301M |
FQ4 2023 (Dec 2023) | 2.49 | 2.49 | 25.167B | 3.37% | 25167M |
FQ3 2023 (Sep 2023) | 0.58 | 0.58 | 23.35B | 8.12% | 23350M |
FQ2 2023 (Jun 2023) | 0.85 | 0.85 | 24.927B | 100% | 24927M |
FQ1 2023 (Mar 2023) | 0.8 | 0.8 | 23.329B | 100% | 23329M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2029 (Sep 2029) | 1.5465 | -- | 1.41931 | 1.69609 | 9 |
FQ2 2029 (Jun 2029) | 1.5447 | -- | 1.41766 | 1.69411 | 6 |
FQ1 2029 (Mar 2029) | 1.5317 | -- | 1.40572 | 1.67985 | 4 |
FQ4 2028 (Oct 2028) | 1.5109 | -- | 1.31805 | 1.85075 | 9 |
FQ3 2028 (Jul 2028) | 1.5134 | -- | 1.32023 | 1.85382 | 11 |
FQ2 2028 (Jun 2028) | 1.5341 | -- | 1.32011 | 1.7068 | 10 |
FQ1 2028 (Mar 2028) | 1.5345 | -- | 1.32045 | 1.70725 | 14 |
FQ4 2027 (Oct 2027) | 1.5245 | -- | 1.32992 | 1.86741 | 8 |
FQ3 2027 (Jul 2027) | 1.5274 | -- | 1.33245 | 1.87097 | 8 |
FQ2 2027 (Jun 2027) | 1.5435 | -- | 1.3282 | 1.71726 | 8 |
FQ1 2027 (Mar 2027) | 1.4823 | -- | 1.27553 | 1.64917 | 8 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2029 (Sep 2029) | 38.6B | -- | 36.16B | 41.48B | 10 |
FQ2 2029 (Jun 2029) | 38.22B | -- | 35.8B | 41.06B | 7 |
FQ1 2029 (Mar 2029) | 37.6B | -- | 35.22B | 40.4B | 5 |
FQ4 2028 (Oct 2028) | 39.15B | -- | 35.31B | 45.93B | 14 |
FQ3 2028 (Jul 2028) | 38.83B | -- | 35.01B | 45.54B | 7 |
FQ2 2028 (Jun 2028) | 38.95B | -- | 34.77B | 42.32B | 7 |
FQ1 2028 (Mar 2028) | 38.57B | -- | 34.43B | 41.91B | 8 |
FQ4 2027 (Oct 2027) | 36.04B | -- | 32.51B | 42.28B | 11 |
FQ3 2027 (Jul 2027) | 35.78B | -- | 32.26B | 41.97B | 8 |
FQ2 2027 (Jun 2027) | 35.86B | -- | 32.01B | 38.96B | 16 |
FQ1 2027 (Mar 2027) | 34.2B | -- | 30.53B | 37.16B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.72 | 0.72 | 100% | |
FQ3 2024 (Sep 2024) | 1 | 1 | 100% | |
FQ2 2024 (Jun 2024) | 0.46 | 0.46 | 100% | |
FQ1 2024 (Mar 2024) | 0.35 | 0.35 | 100% | |
FQ4 2023 (Dec 2023) | 2.49 | 2.49 | 100% | |
FQ3 2023 (Sep 2023) | 0.58 | 0.58 | 100% | |
FQ2 2023 (Jun 2023) | 0.85 | 0.85 | 100% | |
FQ1 2023 (Mar 2023) | 0.8 | 0.8 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $25.71B | $25707M | 100% |
FQ3 2024 (Sep 2024) | $0B | $20.02B | $20016M | 100% |
FQ2 2024 (Jun 2024) | $0B | $25.5B | $25500M | 100% |
FQ1 2024 (Mar 2024) | $0B | $21.3B | $21301M | 100% |
FQ4 2023 (Dec 2023) | $0B | $25.17B | $25167M | 100% |
FQ3 2023 (Sep 2023) | $0B | $23.35B | $23350M | 100% |
FQ2 2023 (Jun 2023) | $0B | $24.93B | $24927M | 100% |
FQ1 2023 (Mar 2023) | $0B | $23.33B | $23329M | 100% |